Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    21873548 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
2 Completed Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
Condition: Leukemia
Interventions: Drug: asparaginase;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: gemtuzumab ozogamicin;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Procedure: allogeneic bone marrow transplantation
3 Completed
Has Results
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
Conditions: Cancer;   Lentigo Maligna
Interventions: Drug: Imiquimod Cream;   Drug: Tazarotene Cream 0.1%

Indicates status has not been verified in more than two years